https://www.prnewswire.com/news-releases/pulmotects-positive-topline-results-for-inhaled-pul-042-against-covid-19-delivered-by-pari-nebulizer-301387361.html
Pulmotect's Positive Topline Results for Inhaled PUL-042 against COVID-19 Delivered by PARI...
/PRNewswire/ -- Pulmotect reported positive topline results from their randomized, placebo-controlled Phase-2 trial of PUL-042 against COVID-19. Patients...
https://pulmotect.com/
Pulmotect, Inc. – Bio-pharmaceutical company developing products for severe respiratory diseases
bio pharmaceutical